Incyte (NASDAQ: INCY) insider files to sell 12743 shares under Rule 144

Rhea-AI Filing Summary

Vijay Iyengar filed a notice to sell 12743 shares of Incyte (INCY) common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate market value of 1388987.00.

The filing states that 196322703 shares of common stock were outstanding. The 12743 shares to be sold were acquired on 02/09/2026 via a stock option exercise paid in cash the same day. The notice also reports prior sales over the past three months, including 95811 shares sold on 01/06/2026 for gross proceeds of 9998255.70.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12743	1388987.00	196322703	02/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/09/2026	Stock Option Exercise	Issuer			12743	02/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
VIJAY IYENGAR 1801 Augustine Cut-Off Wilmington DE 19803	Common	01/06/2026	95811	9998255.70
VIJAY IYENGAR 1801 Augustine Cut-Off Wilmington DE 19803	Common	01/05/2026	16437	1689887.97
VIJAY IYENGAR 1801 Augustine Cut-Off Wilmington DE 19803	Common	12/19/2025	52941	5385677.34
VIJAY IYENGAR 1801 Augustine Cut-Off Wilmington DE 19803	Common	12/16/2025	13388	1317245.32
VIJAY IYENGAR 1801 Augustine Cut-Off Wilmington DE 19803	Common	12/10/2025	23104	2206695.39

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the INCY Form 144 filing by Vijay Iyengar disclose?

The filing discloses a planned Rule 144 sale of Incyte shares. Vijay Iyengar intends to sell 12743 shares of Incyte common stock, listing an aggregate market value of 1388987.00, and provides details on how the shares were acquired and prior sales activity.

How many INCY shares is Vijay Iyengar planning to sell under Rule 144?

The notice covers a proposed sale of 12743 Incyte common shares. These shares are listed with an aggregate market value of 1388987.00 and are part of Incyte’s total 196322703 common shares outstanding as referenced in the filing.

How and when were the INCY shares in this Form 144 acquired?

The 12743 shares were acquired through a stock option exercise. The filing states they were obtained on 02/09/2026 directly from the issuer via a stock option exercise, with the purchase price paid in cash on the same date.

Which broker and exchange are involved in this INCY Rule 144 sale?

The shares are to be sold through Morgan Stanley Smith Barney LLC. Specifically, Executive Financial Services at 1 New York Plaza is listed as broker, and NASDAQ is named as the securities exchange where the 12743 Incyte common shares are intended to be sold.

What recent INCY stock sales by Vijay Iyengar are reported in the filing?

The notice lists several Incyte stock sales in the prior three months. Examples include a sale of 95811 common shares on 01/06/2026 for gross proceeds of 9998255.70, along with multiple additional common stock sales in December 2025.

How many INCY common shares were outstanding according to this Form 144?

The document reports 196322703 Incyte common shares outstanding. This figure provides context for the planned Rule 144 sale of 12743 shares by Vijay Iyengar, indicating the relative size of the proposed transaction against the company’s total common stock base.